Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-0120 and Allopurinol in Gout
NCT05665699Phase 2Completed
- Sponsor
- InventisBio
- Start
- Apr 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of darbinurad in gout, sponsored by InventisBio. Started Apr 2023; status: completed.
02
Drugs
darbinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT05665699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05665699.